PT  - JOURNAL ARTICLE
AU  - Vounckx, Manon
AU  - Tijtgat, Jens
AU  - Dirven, Iris
AU  - Vandenbroucke, Frederik
AU  - Raemaeckers, Steven
AU  - Ilsen, Bart
AU  - Mustapha, Selma Ben
AU  - Loon, Jens Van
AU  - Stevens, Latoya
AU  - Geeraerts, Xenia
AU  - Riet, Ivan Van
AU  - Dufait, Ines
AU  - Tuyaerts, Sandra
AU  - Decoster, Lore
AU  - Ridder, Mark De
AU  - Neyns, Bart
TI  - 694 A randomized phase II clinical trial of SBRT and pembrolizumab with or without intratumoral avelumab/ipilimumab plus CD1c(BDCA-1)<sup>+</sup>/CD141(BDCA-3)<sup>+</sup> myeloid dendritic cells in solid tumors
AID  - 10.1136/jitc-2023-SITC2023.0694
DP  - 2023 Nov 01
TA  - Journal for ImmunoTherapy of Cancer
PG  - A786--A786
VI  - 11
IP  - Suppl 1
4099  - http://jitc.bmj.com/content/11/Suppl_1/A786.short
4100  - http://jitc.bmj.com/content/11/Suppl_1/A786.full
SO  - J Immunother Cancer2023 Nov 01; 11
AB  - Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.